A Study of Anatomical Priors for Deep Learning-Based Segmentation of Pheochromocytoma in Abdominal CT

TL;DR

This study evaluates anatomical priors to enhance deep learning segmentation of pheochromocytoma in abdominal CT scans, demonstrating that organ-specific priors improve accuracy and robustness over broad body-region priors.

Contribution

It introduces novel multi-class anatomical priors based on surrounding organs and shows their effectiveness in improving deep learning-based PCC segmentation accuracy.

Findings

Organ-specific priors outperform broad body-region priors in segmentation accuracy.

The TKA (Tumor + Kidney + Aorta) strategy achieved the highest performance metrics.

Anatomical priors improve tumor burden quantification and generalize across genetic subtypes.

Abstract

Accurate segmentation of pheochromocytoma (PCC) in abdominal CT scans is essential for tumor burden estimation, prognosis, and treatment planning. It may also help infer genetic clusters, reducing reliance on expensive testing. This study systematically evaluates anatomical priors to identify configurations that improve deep learning-based PCC segmentation. We employed the nnU-Net framework to evaluate eleven annotation strategies for accurate 3D segmentation of pheochromocytoma, introducing a set of novel multi-class schemes based on organ-specific anatomical priors. These priors were derived from adjacent organs commonly surrounding adrenal tumors (e.g., liver, spleen, kidney, aorta, adrenal gland, and pancreas), and were compared against a broad body-region prior used in previous work. The framework was trained and tested on 105 contrast-enhanced CT scans from 91 patients at the NIH Clinical Center. Performance was measured using Dice Similarity Coefficient (DSC), Normalized Surface Distance (NSD), and instance-wise F1 score. Among all strategies, the Tumor + Kidney + Aorta (TKA) annotation achieved the highest segmentation accuracy, significantly outperforming the previously used Tumor + Body (TB) annotation across DSC (p = 0.0097), NSD (p = 0.0110), and F1 score (25.84% improvement at an IoU threshold of 0.5), measured on a 70-30 train-test split. The TKA model also showed superior tumor burden quantification (R^2 = 0.968) and strong segmentation across all genetic subtypes. In five-fold cross-validation, TKA consistently outperformed TB across IoU thresholds (0.1 to 0.5), reinforcing its robustness and generalizability. These findings highlight the value of incorporating relevant anatomical context into deep learning models to achieve precise PCC segmentation, offering a valuable tool to support clinical assessment and longitudinal disease monitoring in PCC patients.